Report overview

The report records fiscal 2014 net sales of ¥105,454 million and estimates that Sawai's products reduced Japan's medical-care expenses by approximately ¥200 billion. During the year, the company launched 28 products based on 13 active ingredients.

Document

Report type: Integrated Report
Class: Embedded
Scope: Full report
Fiscal year: 2014-2015
Period: 1 April 2014 – 31 March 2015
Language
Pages
File size
Restatement: Disclosed

Standards & Assurance

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Assurance

Statement included

ESG & Materiality

ESG data

Indicators available in this report:

Employees

Materiality

Assessment
Basis

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown, tailored to your project.

Explore our services